OPIANT PHARMACEUTICALS, INC. Contracts & Agreements

101 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Opiant Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Stock Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2022
Opiant Pharmaceuticals, Inc. 2021 Amended Inducement Equity Incentive Plan
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2021
Opiant Pharmaceuticals, Inc. 2021 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2021
Director Agreement between Opiant Pharmaceuticals, Inc. and Dr. Lorianne Masuoka (March 18, 2021)
Services Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2021
Description of Opiant Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2021
Note Purchase and Security Agreement between Opiant Pharmaceuticals, Inc. and Pontifax Medison Finance et al.
Note Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
Registration Rights Agreement between Opiant Pharmaceuticals, Inc. and Lenders (December 10, 2020)
Registration Rights Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Opiant Pharmaceuticals Third Quarter 2020 Financial Results and Corporate Update
Release Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Master Services Agreement between AptarGroup, Inc. and Opiant Pharmaceuticals, Inc.
Services Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2020
Master Services Agreement between Opiant Pharmaceuticals, Inc. and Summit Biosciences Inc.
Services Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Description of Opiant Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Open Market Sale Agreement between Opiant Pharmaceuticals, Inc. and Jefferies LLC (November 14, 2019)
Equity Distribution Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Amendment No. 2 to License Agreement between Opiant Pharmaceuticals Inc. and Adapt Pharma Operations Limited
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2019
License Agreement between Sanofi and Opiant Pharmaceuticals, Inc. (December 21, 2018)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
BARDA–Opiant Pharmaceuticals Contract for Intranasal Nalmefene Development and Clinical Studies
Supply Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
Director Agreement between Opiant Pharmaceuticals, Inc. and Craig A. Collard (October 29, 2018)
Services Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
Opiant Pharmaceuticals, Inc. Underwriting Agreement with Cantor Fitzgerald & Co. for Common Stock Offering
Underwriting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
BARDA–Opiant Pharmaceuticals Contract for Intranasal Nalmefene Development and Clinical Studies
Supply Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
Development Agreement between Aesica Queenborough Limited and Opiant Pharmaceuticals Inc. for Nalmefene Hydrochloride Device
Development Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Agreement for Reimbursement of Capital Expenditure and Service Fees between Opiant Pharmaceuticals, Inc. and Aesica Queenborough Limited
Financing Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Director Agreement between Opiant Pharmaceuticals, Inc. and Richard Daly, effective June 12, 2018
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
License Agreement between Lightlake Therapeutics Inc. and Adapt Pharma Operations Limited (December 15, 2014)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2018
Executive Employment Agreement between Opiant Pharmaceuticals, Inc. and Roger Crystal
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Executive Employment Agreement between Opiant Pharmaceuticals, Inc. and David O'Toole
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Executive Employment Agreement between Opiant Pharmaceuticals, Inc. and Phil Skolnick
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2018
Opiant Pharmaceuticals, Inc. 2017 Incentive Stock Option Agreement with Employee
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2017
Opiant Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement under 2017 Long-Term Incentive Plan
Warrant Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2017
Opiant Pharmaceuticals, Inc. Restricted Stock Agreement under 2017 Long-Term Incentive Plan
Equity Distribution Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2017
License Agreement between Opiant Pharmaceuticals, Inc. and Aegis Therapeutics, LLC (Effective January 1, 2017)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2017
Supply Agreement between Opiant Pharmaceuticals, Inc. and Aegis Therapeutics, LLC (Effective January 1, 2017)
Supply Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2017
Research & Development Services Agreement between Renaissance Lakewood, LLC and Opiant Pharmaceuticals, Inc.
Services Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2017
Opiant Pharmaceuticals, Inc. 2017 Long-Term Incentive Plan
Bonus & Incentive Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2017
Supplemental Engagement Letter Between Opiant Pharmaceuticals, Inc. and Torreya Partners (Europe) LLP
Advisory Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Opiant Pharmaceuticals, Inc. Offer of Employment to David O’Toole as Chief Financial Officer
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Third Amendment to Senior Advisor Agreement between Opiant Pharmaceuticals, Inc. and Brad Miles
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Amendment to Investment Agreement between Opiant Pharmaceuticals, Inc. and Ernst Welmers
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Amendment to Amended and Restated Consulting Agreement between Opiant Pharmaceuticals, Inc. and LYL Holdings Inc.
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
License Agreement between Lightlake Therapeutics Inc. and Adapt Pharma Operations Limited (December 15, 2014)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2017
Amendment No. 1 to License Agreement between Opiant Pharmaceuticals, Inc. and Adapt Pharma Operations Limited
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Amendment to Investment Agreements between Opiant Pharmaceuticals, Inc. and Potomac Construction Limited
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Employment Agreement Acknowledgement between Opiant Pharmaceuticals, Inc. and Michael Sinclair (March 31, 2017)
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Employment Agreement Acknowledgement between Opiant Pharmaceuticals, Inc. and Roger Crystal (March 31, 2017)
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Purchase and Sale Agreement between Opiant Pharmaceuticals, Inc. and SWK Funding LLC (December 13, 2016)
Purchase Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2017
Amendment No. 1 to License Agreement between Opiant Pharmaceuticals, Inc. and Adapt Pharma Operations Limited
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Third Amendment to Senior Advisor Agreement between Opiant Pharmaceuticals, Inc. and Brad Miles
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Senior Advisor Agreement between Lightlake Therapeutics Inc. and Brad Miles (January 22, 2013)
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
First Amendment to Senior Advisor Agreement between Lightlake Therapeutics Inc. and Brad Miles
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Second Amendment to Senior Advisor Agreement between Lightlake Therapeutics Inc. and Brad Miles
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Employment Agreement between Opiant Pharmaceuticals, Inc. and Phil Skolnick (Chief Scientific Officer)
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Director Agreement between Opiant Pharmaceuticals, Inc. and Thomas T. Thomas (November 4, 2016)
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (April 16, 2013)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Amendment to Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (October 15, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (May 30, 2013)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Amendment to Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (October 15, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Investment Agreement between Lightlake Therapeutics Inc. and Ernst Welmers (May 15, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Amendment to Investment Agreement between Lightlake Therapeutics Inc. and Ernst Welmers (October 15, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Amended and Restated Interest Agreement between Opiant Pharmaceuticals, Inc. and Valour Fund, LLC
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (September 9, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Letter Amendment to Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (October 31, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Letter Agreement Amending Investment Agreement Between Lightlake Therapeutics Inc. and Potomac Construction Limited (October 31, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (December 8, 2015)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (December 20, 2013)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (September 17, 2014)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Investment Agreement between Lightlake Therapeutics Inc. and Potomac Construction Limited (July 20, 2015)
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Amended and Restated Interest Agreement between Lightlake Therapeutics Inc. and Valour Fund, LLC
Investment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Regulatory and Strategic Advisor Consultancy Agreement between Lightlake Therapeutics Inc. and Mary Pendergast
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2016
Financial Advisory Engagement Agreement between Lightlake Therapeutics Inc. and Torreya Partners (Europe) LLP
Advisory Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Amended and Restated Material Transfer, Option and Research License Agreement between Opiant Pharmaceuticals, Inc. and Aegis Therapeutics, LLC
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Exclusive License Option Agreement between Aegis Therapeutics, LLC and Opiant Pharmaceuticals, Inc. (April 26, 2016)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2016
Director Agreement between Opiant Pharmaceuticals, Inc. and Ann MacDougall (May 5, 2016)
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Director Agreement between Opiant Pharmaceuticals, Inc. and Dr. Gabrielle Silver (May 5, 2016)
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Third Amendment to Employment Agreement between Opiant Pharmaceuticals, Inc. and Michael Sinclair
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Third Amendment to Executive Letter of Reappointment between Opiant Pharmaceuticals, Inc. and Roger Crystal
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Third Amendment to Executive Letter of Appointment between Opiant Pharmaceuticals, Inc. and Kevin Pollack, Esq.
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Lightlake Therapeutics Inc. Non-Qualified Stock Option Grant to Dr. Michael Sinclair
Warrant Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
Lightlake Therapeutics Inc. Non-Qualified Stock Option Grant to Dr. Roger Crystal
Warrant Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
Lightlake Therapeutics Inc. Non-Qualified Stock Option Grant Agreement with Kevin Pollack
Warrant Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
Lightlake Therapeutics Inc. Non-Qualified Stock Option Grant Agreement with Geoffrey Wolf
Warrant Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
License Agreement between Lightlake Therapeutics Inc. and Adapt Pharma Operations Limited (December 15, 2014)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2015
Material Transfer, Option and Research License Agreement between Aegis Therapeutics, LLC and Lightlake Therapeutics, Inc.
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
Amendment No. 2 to Material Transfer, Option and Research License Agreement between Aegis Therapeutics, LLC and Lightlake Therapeutics Inc.
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
License Agreement between Lightlake Therapeutics Inc. and Adapt Pharma Operations Limited (December 15, 2014)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2015
Material Transfer, Option and Research License Agreement between Aegis Therapeutics, LLC and Lightlake Therapeutics, Inc.
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
License Agreement between Lightlake Therapeutics Inc. and Adapt Pharma Operations Limited (December 15, 2014)
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2015
Material Transfer, Option and Research License Agreement between Aegis Therapeutics, LLC and Lightlake Therapeutics, Inc.
License Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
Second Amendment to Employment Agreement between Lightlake Therapeutics Inc. and Michael Sinclair
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Second Amendment to Executive Letter of Reappointment between Lightlake Therapeutics Inc. and Roger Crystal
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Second Amendment to Executive Letter of Appointment between Lightlake Therapeutics Inc. and Kevin Pollack, Esq.
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Amendment to Employment Agreement between Lightlake Therapeutics Inc. and Michael Sinclair
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2013
Amendment to Executive Letter of Reappointment between Lightlake Therapeutics Inc. and Roger Crystal
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2013
Amendment to Executive Letter of Appointment between Lightlake Therapeutics Inc. and Kevin Pollack, Esq.
Employment Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2013
Director Compensation and Equity Incentive Agreement between Lightlake Therapeutics Inc. and Geoffrey Wolf
Warrant Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2013
Common Stock Purchase Agreement among Pelikin Group, Belmont Partners, LLC, and Madrona Ventures, Inc.
Purchase Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
VA
2009
Purchase Agreement between Madrona Ventures, Inc. and John David Sinclair for Patent Rights Exchange
Purchase Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2009
Separation Agreement and General Release between Kevin Pollack and Opiant Pharmaceuticals, Inc.
Separation Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2017
Agreement and Plan of Merger between Opiant Pharmaceuticals, Inc. (Nevada) and Opiant Pharmaceuticals, Inc. (Delaware)
Merger Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
DE
2017
Sublease Agreement between Standish Management, LLC and Opiant Pharmaceuticals, Inc. for 201 Santa Monica Blvd, Santa Monica, CA
Lease Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
CA
2017
Amended and Restated Consulting Agreement between LYL Holdings Inc. and Opiant Pharmaceuticals, Inc.
Consulting Agreements
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
US Patent Application: Method for Treating Eating Disorders by Selective Extinction with Transdermal Naloxone (Inventor: John David Sinclair)
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2009
European Patent Specification EP 1 681 057 B1 – Use of Naloxone for Treating Eating Disorders (Sinclair)
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2009